Market News

Westfield Capital Management Company LP Increased Jazz Pharmaceuticals Plc (JAZZ) Holding; Cibc World Markets Has Increased Cboe Hldgs (Call) (CBOE) Position

Westfield Capital Management Company Lp increased Jazz Pharmaceuticals Plc (JAZZ) stake by 8.71% reported in 2017Q3 SEC filing. Westfield Capital Management Company Lp acquired 115,217 shares as Jazz Pharmaceuticals Plc (JAZZ)’s stock rose 8.72%. The Westfield Capital Management Company Lp holds 1.44 million shares with $210.38 million value, up from 1.32M last quarter. Jazz Pharmaceuticals Plc now has $8.41B valuation. The stock increased 0.73% or $1.02 during the last trading session, reaching $140.28. About 239,659 shares traded. Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) has risen 1.25% since February 6, 2017 and is uptrending. It has underperformed by 15.45% the S&P500.

Cibc World Markets Inc increased Cboe Hldgs Inc (Call) (CBOE) stake by 2285.27% reported in 2017Q3 SEC filing. Cibc World Markets Inc acquired 121,005 shares as Cboe Hldgs Inc (Call) (CBOE)’s stock rose 5.07%. The Cibc World Markets Inc holds 126,300 shares with $13.59M value, up from 5,295 last quarter. Cboe Hldgs Inc (Call) now has $13.31B valuation. The stock decreased 10.10% or $13.19 during the last trading session, reaching $117.34. About 4.60M shares traded or 328.93% up from the average. Cboe Global Markets, Inc. (NASDAQ:CBOE) has risen 34.37% since February 6, 2017 and is uptrending. It has outperformed by 17.67% the S&P500.

Among 20 analysts covering CBOE Holdings Inc (NASDAQ:CBOE), 8 have Buy rating, 2 Sell and 10 Hold. Therefore 40% are positive. CBOE Holdings Inc had 68 analyst reports since August 4, 2015 according to SRatingsIntel. On Tuesday, October 10 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”. The rating was maintained by UBS on Wednesday, January 6 with “Neutral”. RBC Capital Markets maintained it with “Buy” rating and $9000 target in Monday, June 19 report. On Friday, September 4 the stock rating was maintained by JP Morgan with “Neutral”. The company was maintained on Tuesday, January 16 by Jefferies. The stock of Cboe Global Markets, Inc. (NASDAQ:CBOE) has “Underweight” rating given on Tuesday, August 9 by Barclays Capital. The rating was upgraded by Zacks on Tuesday, August 25 to “Hold”. As per Thursday, October 19, the company rating was maintained by Citigroup. The rating was upgraded by Wells Fargo on Tuesday, October 4 to “Outperform”. Jefferies maintained the shares of CBOE in report on Tuesday, August 22 with “Hold” rating.

Cibc World Markets Inc decreased Gilead Sciences Inc (NASDAQ:GILD) stake by 107,801 shares to 646,783 valued at $52.40 million in 2017Q3. It also reduced Sun Life Finl Inc (Call) (NYSE:SLF) stake by 114,700 shares and now owns 211,000 shares. Sk Telecom Ltd (NYSE:SKM) was reduced too.

Investors sentiment decreased to 1.47 in Q3 2017. Its down 0.27, from 1.74 in 2017Q2. It dropped, as 38 investors sold CBOE shares while 88 reduced holdings. 50 funds opened positions while 135 raised stakes. 91.13 million shares or 2.65% more from 88.78 million shares in 2017Q2 were reported. Usa Financial Portformulas holds 39,511 shares or 1.01% of its portfolio. Fil Ltd owns 317,108 shares for 0.1% of their portfolio. State Treasurer State Of Michigan holds 0.03% or 34,200 shares. Kentucky Retirement Ins Tru Fund reported 0.05% in Cboe Global Markets, Inc. (NASDAQ:CBOE). Putnam Invests Ltd holds 0% or 1,900 shares. Cibc Asset Mgmt holds 11,130 shares or 0.01% of its portfolio. Fmr Lc holds 0.13% or 10.18 million shares. Ameritas Prtnrs owns 2,190 shares. Morgan Stanley holds 296,899 shares. Retirement System Of Alabama reported 0.06% of its portfolio in Cboe Global Markets, Inc. (NASDAQ:CBOE). 84,320 are held by Stifel Financial Corporation. Highland Cap Management LP invested in 0.35% or 74,750 shares. West Oak Cap Limited Liability Company owns 475 shares. Oppenheimer Asset Management owns 0% invested in Cboe Global Markets, Inc. (NASDAQ:CBOE) for 69 shares. Nomura Asset Management Limited invested in 0.03% or 22,614 shares.

Since August 14, 2017, it had 0 buys, and 7 insider sales for $22.05 million activity. 200,000 shares valued at $19.53 million were sold by Mitchell Christopher on Tuesday, August 15. Another trade for 1,520 shares valued at $147,653 was made by Stone Carole E on Monday, August 14. $631,400 worth of stock was sold by Tilly Edward T on Monday, December 11. Isaacson Christopher A sold 7,020 shares worth $706,282. English Frank E. Jr. sold 700 shares worth $69,713. 4,000 shares were sold by REYNOLDS DAVID S, worth $436,460.

Among 21 analysts covering Jazz Pharmaceuticals (NASDAQ:JAZZ), 16 have Buy rating, 0 Sell and 5 Hold. Therefore 76% are positive. Jazz Pharmaceuticals had 71 analyst reports since August 3, 2015 according to SRatingsIntel. SunTrust maintained Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) on Thursday, June 2 with “Buy” rating. RBC Capital Markets maintained the stock with “Buy” rating in Tuesday, June 27 report. The stock of Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) has “Buy” rating given on Friday, September 22 by Cowen & Co. As per Friday, February 19, the company rating was initiated by Wells Fargo. As per Wednesday, June 7, the company rating was maintained by BMO Capital Markets. The firm has “Buy” rating given on Thursday, July 27 by Cantor Fitzgerald. The firm earned “Hold” rating on Friday, October 13 by Mizuho. BMO Capital Markets maintained the stock with “Buy” rating in Tuesday, October 24 report. The stock of Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) has “Buy” rating given on Thursday, September 14 by RBC Capital Markets. On Wednesday, May 11 the stock rating was maintained by UBS with “Buy”.

Since August 10, 2017, it had 0 insider purchases, and 10 sales for $2.44 million activity. $29,730 worth of Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) was sold by MILLER MICHAEL PATRICK. Shares for $94,248 were sold by RIEDEL NORBERT G on Thursday, August 10. The insider COZADD BRUCE C sold 3,000 shares worth $450,000. The insider ENRIGHT PATRICK G sold 351 shares worth $52,088. 1,304 Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) shares with value of $186,884 were sold by Treacy Paul. $170,699 worth of Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) shares were sold by Schnee Elmar. On Thursday, August 10 the insider O’Keefe Kenneth W sold $94,248.

Investors sentiment decreased to 1.03 in 2017 Q3. Its down 0.36, from 1.39 in 2017Q2. It is negative, as 39 investors sold JAZZ shares while 82 reduced holdings. 31 funds opened positions while 94 raised stakes. 53.58 million shares or 3.54% more from 51.74 million shares in 2017Q2 were reported. Nomura Asset reported 0.01% stake. Nationwide Fund has invested 0.01% in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Ameriprise Fincl has 0.02% invested in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Millennium Mgmt Ltd stated it has 130,490 shares or 0.03% of all its holdings. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.24% or 175,595 shares in its portfolio. 15,412 are held by Bingham Osborn Scarborough Ltd Company. The Ontario – Canada-based Hillsdale Investment Management has invested 0.01% in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Renaissance Technology invested in 0.21% or 1.22M shares. Bancorpsouth Incorporated has 3,273 shares for 0.05% of their portfolio. Ohio-based Fifth Third Savings Bank has invested 0% in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Northwestern Mutual Wealth Management reported 187 shares stake. Tdam Usa Incorporated holds 4,879 shares. Jpmorgan Chase & stated it has 1.67 million shares. State Board Of Administration Of Florida Retirement Systems, a Florida-based fund reported 3,731 shares. New Jersey-based Brave Asset has invested 0.13% in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ).

Westfield Capital Management Company Lp decreased Flowserve Corp (NYSE:FLS) stake by 18,325 shares to 978,274 valued at $41.67M in 2017Q3. It also reduced Msci Inc (NYSE:MSCI) stake by 18,259 shares and now owns 494,635 shares. Red Hat Inc (NYSE:RHT) was reduced too.

Leave a Reply

Your email address will not be published. Required fields are marked *